{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:56:49Z","timestamp":1780628209112,"version":"3.54.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejim.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T03:12:12Z","timestamp":1370401932000},"page":"492-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Atypical hemolytic uremic syndrome: From the rediscovery of complement to targeted therapy"],"prefix":"10.1016","volume":"24","author":[{"given":"Fadi","family":"Fakhouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.05.008_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneph0670","article-title":"Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?","volume":"3","author":"Fakhouri","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.ejim.2013.05.008_bb0010","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2013.05.008_bb0015","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic\u2013uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.008_bb0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2013.05.008_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-14-3","article-title":"Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome","volume":"14","author":"Sallee","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ejim.2013.05.008_bb0030","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1182\/blood-2005-03-0848","article-title":"Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases","volume":"106","author":"Fakhouri","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.05.008_bb0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08099.x","article-title":"The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab","volume":"149","author":"Kelly","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2013.05.008_bb0040","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2013.05.008_bb0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(09)60001-5","article-title":"Eculizumab for paroxysmal nocturnal haemoglobinuria","volume":"373","author":"Parker","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.05.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.985.985","article-title":"Eculizumab (ECU) safety and efficacy in atypical hemolytic uremic syndrome (aHUS) patients with long disease duration and chronic kidney disease (CKD): 2-year results","volume":"120","author":"Licht","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.05.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V120.21.2084.2084","article-title":"Eculizumab (ECU) in atypical hemolytic uremic syndrome (aHUS) patients with progressing thrombotic microangiopathy (TMA): 2-year data","volume":"120","author":"Greenbaum","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.05.008_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.md.0000133622.03370.07","article-title":"Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement","volume":"83","author":"Coppo","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.ejim.2013.05.008_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic\u2013uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T16:32:16Z","timestamp":1595867536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0953620513001362"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.008","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical hemolytic uremic syndrome: From the rediscovery of complement to targeted therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}